Today's News: Middle East: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today's News: Middle East.

Press releases published on November 4, 2026

Nov. 4, 2026

MazeBolt Named One of Top Startups in the DUN'S 100 Ranking for the Third Year Running

Indeterminate GlobeNewswire

Nov. 4, 2026

Clene Reports Third Quarter 2026 Financial Results and Recent Operating Highlights

Indeterminate GlobeNewswire

Nov. 4, 2026

Aprea Therapeutics Announces Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 4, 2026

Tango and Erasca Initiate Phase 1/2 Study of Oral PRMT5 Inhibitor Vopimetostat in Combination with Pan-RAS Molecular Glue ERAS-0015

Indeterminate GlobeNewswire

Nov. 4, 2026

CollPlant Announces Proposed Name Change to OptiPhi Computing Reflecting Expansion to Computing with Light

Indeterminate GlobeNewswire

Nov. 4, 2026

Rhythm Pharmaceuticals Announces NICE Guidance for IMCIVREE® (Setmelanotide) Updated to Include Adults Living with Bardet-Biedl Syndrome

Indeterminate GlobeNewswire

Nov. 4, 2026

Electra Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference in London

Indeterminate GlobeNewswire

Nov. 4, 2026

Processa Pharmaceuticals Announces Key Leadership Appointments

Indeterminate GlobeNewswire

Nov. 4, 2026

Septerna Announces Selection of SEP-204 as Development Candidate for Graves' Disease and TED and Reports Preclinical Data at the 2026 American Thyroid Association Annual Meeting

Indeterminate GlobeNewswire

Nov. 4, 2026

UroGen Reports $68.0 Million of ZUSDURI Revenue and Provides Third Quarter 2026 Financial Results and Highlights

Indeterminate GlobeNewswire

Nov. 4, 2026

Greenland Mines Welcomes Greenland Parliament’s Approval of Landmark U.S.-Denmark-Greenland Security Agreement

Indeterminate GlobeNewswire

Nov. 4, 2026

Actuate Therapeutics to Present Promising Preclinical Data Demonstrating Antitumor and Immune Activation Activity of Elraglusib Oral Tablet in Advanced Melanoma Models at ENA 2026

Indeterminate GlobeNewswire

Nov. 4, 2026

Neuronetics Reports Third Quarter 2026 Financial and Operating Results

Indeterminate GlobeNewswire

Nov. 4, 2026

Structure Therapeutics to Participate in the Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire

Nov. 4, 2026

Lifecore Biomedical Reports Financial Results for the Third Quarter Ended September 30, 2026, and Provides Corporate Update

Indeterminate GlobeNewswire

Nov. 4, 2026

Qarakal Quantum to Deliver Keynote Presentation at World Quantum Cannes Festival

Indeterminate GlobeNewswire

Nov. 4, 2026

BioCryst Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 4, 2026

Odyssey Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update 

Indeterminate GlobeNewswire

Nov. 4, 2026

Verano Expands Florida Retail Footprint to 87 Locations with Grand Opening of MÜV Fernandina Beach, the Company’s 164th Dispensary Nationwide

Indeterminate GlobeNewswire

Nov. 4, 2026

Brunswick Exploration Reports 1.73% Li2O Over 302 Meters Including 142 Meters at 1.97% Li2O at the Anatacau Main Project

Indeterminate GlobeNewswire